There are 86 papers on refractive error in aging research: 4 trials and 62 observational studies in people, 3 in animals, 9 reviews.
4 new papers in 30 daysSee all 185 papers on refractive error
“we found age (OR = 1.107, 95% CI: 1.094-1.120) and refractive error (OR = 1.352, 95% CI: 1.127-1.622) were independent risk factors.”
- Human trial4
- Humans62
- Animals3
- In silico6
Upstream
1Menopause
no changein humans1
1 study
Menopause
no changein humans1
Menopause was not clearly linked with refractive error in humans (postmenopausal compared with premenopausal women).
Humanspostmenopausal compared with premenopausal womenfemalesn = 62
Associations
6Age
upin humans1
1 study
Age
upin humans1
Age is associated with refractive error in humans.
Humans
Objective vision impairment without subjective visual disturbance
upin humans1
1 study
Objective vision impairment without subjective visual disturbance
upin humans1
Objective vision impairment without subjective visual disturbance is associated with refractive error in humans (OVI without SVD vs OVI with SVD) (83.0% vs. 66.8%, p < 0.001).
HumansOVI without SVD vs OVI with SVDn = 829
Timed Up and Go test
downin humans1OR 1.47
1 study
Timed Up and Go test
downin humans1OR 1.47
Refractive error is associated with timed Up and Go test in humans (elderly patients) (OR 1.47, 95% CI 1.14-2.53).
Humanselderly patientsn = 481
Environmental tobacco smoke exposure
upin humans1
1 study
Environmental tobacco smoke exposure
upin humans1
Environmental tobacco smoke exposure is associated with refractive error in humans (early-life exposure).
Reviewearly-life exposure
Age-related cataract
upin humans1OR 1.352
1 study
Age-related cataract
upin humans1OR 1.352
Refractive error is associated with age-related cataract in humans (Residents of the Jingan district of Shanghai) (OR 1.352, 95% CI 1.127–1.622).
HumansResidents of the Jingan district of Shanghaieyen = 2,894
Visual impairment
downin humans1OR 0.36
1 study
Visual impairment
downin humans1OR 0.36
Refractive error is linked with a lower risk of visual impairment in humans (OR 0.36, p<0.001).
Humans
Trial sponsors
Company2 trials50 people
Company1 trial49 people
Shanghai Eye Disease Prevention and Treatment Center
1 trialPhase 4144 people
Pontificia Universidad Catolica de Chile
1 trialPhase 430 people
6 trialsPhase 31,217 people
Shahid Beheshti University of Medical Sciences
1 trialPhase 1
The Queen'S University of Belfast
1 trial821 people
1 trial50 people